Weaker expectations for the oil & gas business
07/11/19 -"This led to an impairment (92% for goodwill) on the former Rhodia and Chemlogics activities (Novecare – Advance Formulations), which damaged the Q3 figures and came fully out of the blue. In ..."
Pages
60
Language
English
Published on
07/11/19
You may also be interested by these reports :
29/06/25
We have incorporated the latest figures and anticipate another challenging year for the company, with no division acting as a significant drag. While ...
27/06/25
The divesture of the Indian decorative paints is a well done deal, but the funds will not be well allocated. While we appreciate the deleveraging, we ...
25/06/25
The global economic uncertainties have increased recently, influenced by President Trump’s trade war and the escalation of the Israeli-Iranian ...
03/06/25
We view the divestment of Catalyst Technologies as a strategic misstep, although we acknowledge that Johnson Matthey’s (JM) current focus is on free ...